- Home
- TTD vs PODD Comparison
TTD vs PODD Comparison
Compare TTD & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTD | PODD |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2B | 22.1B |
| IPO Year | 2016 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TTD | PODD |
|---|---|---|
| Price | $40.05 | $304.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 34 | 19 |
| Target Price | $82.39 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 13.6M | 765.6K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.00 | N/A |
| EPS | 0.88 | ★ 3.45 |
| Revenue | ★ $2,790,505,000.00 | $2,521,800,000.00 |
| Revenue This Year | $19.44 | $32.55 |
| Revenue Next Year | $16.13 | $20.39 |
| P/E Ratio | ★ $45.48 | $88.24 |
| Revenue Growth | 20.82 | ★ 27.11 |
| 52 Week Low | $38.23 | $230.05 |
| 52 Week High | $139.34 | $354.88 |
Technical Indicators
Market Signals| Indicator | TTD | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 38.86 | 40.94 |
| Support Level | $38.25 | $303.20 |
| Resistance Level | $40.71 | $317.34 |
| Average True Range (ATR) | 1.44 | 13.12 |
| MACD | 0.33 | -2.82 |
| Stochastic Oscillator | 49.39 | 3.14 |
Price Performance
Historical ComparisonAbout TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.